Mayo Clinic on MSN
COVID-19 vaccines: Get the facts
Find out about the COVID-19 vaccines, the benefits of COVID-19 vaccination and the possible side effects.
MedPage Today on MSN
JAMA journal publishes COVID vaccine study squelched by CDC leader
Bhattacharya attacked study's test-negative design, a staple of vaccine effectiveness rese ...
Novavax (NVAX) stock is in focus as Shah Capital again slams the company's leadership despite shareholder backing at the AGM. Read more here.
Add Yahoo as a preferred source to see more of our stories on Google. Heeney has designed a fundamental new vaccine technology that could prevent future pandemics before they begin. (CREDIT: ...
The COVID-19 vaccine lowered the risk of cardiovascular issues associated with the virus by around 40 percent, according to new research. The study, which was published in JAMA Internal Medicine on ...
A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George's University hospital in London, on Oct. 7, 2020. (Alastair Grant/AP) (CN) — Billions of euros, ...
The coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 - strokes, heart attacks, and hospitalization from heart disease - by about 40 percent, according to a new ...
A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now ...
Share on Pinterest What does the ‘world-first’ vaccine designed by artificial intelligence mean for public health? Image credit: Luis Velasco/Getty Images Researchers at the University of Cambridge ...
Although most Americans have eschewed seasonal COVID-19 vaccines, the updated shots continue to show significant protection against cardiovascular disease, especially for those over age 75 and those ...
Moderna (MRNA) has surged 94% in 2026 so far, crushing Pfizer (PFE) at just +4% and beating Novavax (NVAX) at +41%, as Moderna's leadership restructuring has signaled a 2027-2028 product launch push.
You can listen to more articles from The Conversation, narrated by Noa, here. Researchers at the University of Cambridge have developed what they describe as a fundamentally new type of vaccine using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results